Phase II, double-blind, placebo-controlled study to explore the ELF and plasma concentration as well as safety of Inhaled Alpha-1 Antitrypsin in Alpha-1 Antitrypsin Deficiency subjects

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences

Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation